価格表

在庫・価格 : 2024年05月18日 08時11分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Synuclein-α, Goat-Poly, Biotin
データシート※最新のデータシートでない場合があります
BAF1338 RSDアールアンドディー システムス
R&D Systems, Inc.
50 μg ¥118,000
(未発注)
追加

在庫・価格 : 2024年05月18日 08時11分 現在

Anti-Synuclein-α, Goat-Poly, Biotin

  • 商品コード:BAF1338
  • メーカー:RSD
  • 包装:50μg
  • 価格: ¥118,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Hong Z et al. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson"s disease. Brain 2010 Mar;133(Pt 3):713-26
Hong Z et al
2010/01/01
Application: Luminex Assay Development, Sample Type: CSF PubMed
2 Wang XY et al. Using gastrocnemius sEMG and plasma α-synuclein for the prediction of freezing of gait in Parkinson"s disease patients. PLoS ONE 2014;9(2):e89353
Wang XY et al
2014/01/01
Application: Magnetic bead-based Luminex as, Sample Type: Plasma PubMed
3 Kang W et al. Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson"s disease patients. Sci Rep 2016 Jun;6:28143
Kang W et al
2016/01/01
Application: Luminex Assay Development, Sample Type: Saliva PubMed
4 Matsumoto J et al. Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson"s disease? Acta N
Matsumoto J et al
2017/01/01
Species: Human, Applications: Luminex Assay Development PubMed
5 Miners JS et al. Endothelin-converting enzymes degrade α-synuclein and are reduced in dementia with Lewy bodies. J. Neurochem. 2017 Apr;141(2):275-286
Miners JS et al
2017/01/01
PubMed
6 Sinclair LI et al. Visual hallucinations in Alzheimer"s disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas. Alzheimers Res Ther 2019 0
Sinclair LI et al
2019/01/01
PubMed
  • No.: 1
  • 文献情報:
    Hong Z et al. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson"s disease. Brain 2010 Mar;133(Pt 3):713-26
    Hong Z et al
    2010/01/01
  • 備考:
    Application: Luminex Assay Development, Sample Type: CSF
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Wang XY et al. Using gastrocnemius sEMG and plasma α-synuclein for the prediction of freezing of gait in Parkinson"s disease patients. PLoS ONE 2014;9(2):e89353
    Wang XY et al
    2014/01/01
  • 備考:
    Application: Magnetic bead-based Luminex as, Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Kang W et al. Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson"s disease patients. Sci Rep 2016 Jun;6:28143
    Kang W et al
    2016/01/01
  • 備考:
    Application: Luminex Assay Development, Sample Type: Saliva
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Matsumoto J et al. Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson"s disease? Acta N
    Matsumoto J et al
    2017/01/01
  • 備考:
    Species: Human, Applications: Luminex Assay Development
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Miners JS et al. Endothelin-converting enzymes degrade α-synuclein and are reduced in dementia with Lewy bodies. J. Neurochem. 2017 Apr;141(2):275-286
    Miners JS et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Sinclair LI et al. Visual hallucinations in Alzheimer"s disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas. Alzheimers Res Ther 2019 0
    Sinclair LI et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed